Results 241 to 250 of about 2,314,861 (318)
Objective A leading cause of death among patients with scleroderma (SSc), interstitial lung disease (ILD) remains challenging to prognosticate. The discovery of biomarkers that accurately determine which patients would benefit from close monitoring and aggressive therapy would be an essential clinical tool.
Cristina M. Padilla +13 more
wiley +1 more source
Objective We aimed to identify unique disease trajectories within rheumatoid arthritis–associated interstitial lung disease (RA‐ILD) based on longitudinal forced vital capacity (FVC) values and their associated clinical outcomes. Methods We performed a cohort study of RA‐ILD within the Veterans Health Administration from 1999 to 2021.
Bryant R. England +9 more
wiley +1 more source
Risk Management of Medication Errors: Improving the Quality of Pharmacotherapeutic Practice. [PDF]
Despott RA, Vella Bonanno P, Gauci C.
europepmc +1 more source
Developing Enterprise Risk Management Disclosure Index using Factor Analysis
Sharifah Faatihah Syed Mohd Fuzi +3 more
openalex +2 more sources
Correction: Leveraging real-world data for safety signal detection and risk management in pre- and post-market settings. [PDF]
Gavin KM, Sundermann ML, Wieland A.
europepmc +1 more source

